About Upexi, Inc. 
Upexi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 5 Schemes (1.61%)
Foreign Institutions
Held by 14 Foreign Institutions (5.3%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Sep 2025)
Net Profit:
67 Million
Pharmaceuticals & Biotechnology
USD 133 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.07
-11.23%
0.63






